If they have a positive trial announcement there will be time to get in and ride this up. No big pharma will buy this until then.
This should be helpful in raising awareness of INO's technology and produce a breakout in the stock.
Anyone know how this will effect SSH?
If they have a few of their products take off worldwide $100/sh easily.
Sentiment: Strong Buy
Common will go the way of the dodo bird. Worthless.